KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Bristol Myers Squibb (BMY) over the last 17 years, with Q4 2025 value amounting to $5.0 million.

  • Bristol Myers Squibb's Exchange Rate Effect rose 10340.14% to $5.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $195.0 million, marking a year-over-year increase of 24233.58%. This contributed to the annual value of $195.0 million for FY2025, which is 24233.58% up from last year.
  • Per Bristol Myers Squibb's latest filing, its Exchange Rate Effect stood at $5.0 million for Q4 2025, which was up 10340.14% from -$4.0 million recorded in Q3 2025.
  • In the past 5 years, Bristol Myers Squibb's Exchange Rate Effect registered a high of $128.0 million during Q2 2025, and its lowest value of -$147.0 million during Q4 2024.
  • In the last 5 years, Bristol Myers Squibb's Exchange Rate Effect had a median value of -$6.0 million in 2023 and averaged -$1.6 million.
  • Per our database at Business Quant, Bristol Myers Squibb's Exchange Rate Effect tumbled by 49444.44% in 2022 and then surged by 68181.82% in 2025.
  • Bristol Myers Squibb's Exchange Rate Effect (Quarter) stood at -$54.0 million in 2021, then soared by 275.93% to $95.0 million in 2022, then dropped by 17.89% to $78.0 million in 2023, then plummeted by 288.46% to -$147.0 million in 2024, then surged by 103.4% to $5.0 million in 2025.
  • Its last three reported values are $5.0 million in Q4 2025, -$4.0 million for Q3 2025, and $128.0 million during Q2 2025.